Advances in the understanding and management of the irritable bowel syndrome.
Kellow
J E
JE
University of Sydney, Department of Medicine, Royal North Shore Hospital, St Leonards, NSW.
Langeluddecke
P M
PM
D003109:Colonic Diseases, Functional / Q000150:complications / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D003937:Diagnosis, Differential; D004043:Dietary Fiber / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005769:Gastrointestinal Motility; D006801:Humans; D009497:Neurotic Disorders / Q000209:etiology; D010276:Parasympatholytics / Q000627:therapeutic use; D010342:Patient Acceptance of Health Care; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000627:therapeutic use; D013315:Stress, Psychological / Q000150:complications
D004043:Dietary Fiber; D010276:Parasympatholytics; D011619:Psychotropic Drugs